Pipeline drug companies must scope the long-term competition to win seed funding, says Pfizer

22 April 2020 (Last Updated April 22nd, 2020 12:46)

According to Barbara Dalton, Pfizer Ventures senior managing partner, in order to win Pfizer Ventures' funding, drug development start-ups must have carried out their due diligence via long-term competitors, instead of predicting competition based on present environment.

In March, Pfizer announced the joint development of a potential Covid-19 messenger ribonucleic acid (mRNA) vaccine with BioNTech. More information on drugs and vaccines in development for Covid-19 can be found in GlobalData’s Drugs database.